Serum uric acid is associated with new-onset diabetes in hypertensive patients with left ventricular hypertrophy: The LIFE Study (Q43079090)

13 November 2017

title

Serum uric acid is associated with new-onset diabetes in hypertensive patients with left ventricular hypertrophy: The LIFE Study (English)

1 reference

left ventricular hypertrophy

13 November 2017

main subject

1 reference

8

Björn Dahlöf

0 references

Sverre E. Kjeldsen

4

object named as

Sverre E Kjeldsen

1 reference

13 November 2017

9

Richard B Devereux

1 reference

13 November 2017

Benedicte P Wiik

1

1 reference

13 November 2017

Anne C K Larstorp

2

1 reference

13 November 2017

Aud Høieggen

3

1 reference

13 November 2017

Michael Hecht Olsen

5

1 reference

13 November 2017

Hans Ibsen

6

1 reference

13 November 2017

Lars Lindholm

7

1 reference

13 November 2017

Peter M Okin

10

1 reference

13 November 2017

Kristian Wachtell

11

1 reference

13 November 2017

publication date

29 April 2010

1 reference

Journal of Clinical Hypertension

13 November 2017

published in

1 reference

13 November 2017

volume

23

1 reference

13 November 2017

issue

8

1 reference

13 November 2017

page(s)

845-851

1 reference

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.89

7 January 2021

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.89

7 January 2021

The impact of serum uric acid on cardiovascular outcomes in the LIFE study

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.89

7 January 2021

Assessment of temperature, proximity, and course of the esophagus during radiofrequency ablation within the left atrium

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.89

7 January 2021

Serum uric acid and incident diabetes in Mauritian Indian and Creole populations

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.89

7 January 2021

High serum uric acid as a novel risk factor for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.89

7 January 2021

High serum uric acid as a novel risk factor for type 2 diabetes: response to Dehghan et al.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.89

7 January 2021

High serum uric acid as a novel risk factor for type 2 diabetes: response to Dehghan et al

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.89

7 January 2021

In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.89

7 January 2021

Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.89

7 January 2021

Prevalence of the metabolic syndrome in individuals with hyperuricemia

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.89

7 January 2021

Association between serum uric acid and development of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.89

7 January 2021

Serum uric acid, mortality and glucose control in patients with Type 2 diabetes mellitus: a PreCIS database study

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.89

7 January 2021

Identifiers

DOI

10.1038/AJH.2010.89

1 reference

13 November 2017

1 reference